They then applied this vaccination in a murine model of osteoarthritis, resulting in high anti-NGF antibody titers and reversibly alleviated pain behaviors (improved weight-bearing on the affected limb), both in prophylactic and therapeutic vaccination regimens [23]. The gene discussed is NGF; the disease is osteoarthritis.